The primary research objective of the Institute for Diabetes Research and Metabolic Diseases (IDM) is diabetes prevention and its personalized therapy

The IDM has access to data from well-phenotyped cohort and multicenter studies involving people with an increased risk of diabetes. Organ crosstalk—the interaction and role of the brain, liver and pancreas in the development of prediabetes and diabetes—is of particular interest. To this end, basic scientists cooperate closely with clinical researchers.

Translational Diabetology 

• Prof. Dr. Andreas Birkenfeld, Prof. Dr. Reiner Jumpertz-von Schwartzenberg 

Prevention of Type 2 Diabetes 

• Prof. Dr. Andreas Fritsche 

Gestational Diabetes

• Dr. Julia Sbierski-Kind (Junior Research Group) 

Pathophysiology of Prediabetes 

• Prof. Dr. Norbert Stefan, Prof. Dr. Dr. Fritz Schick 

Pathophysiology of Nephrotic Syndrome 

• Adjunct Prof. Dr. Ferruh Artunc 

Molecular Diabetology and Exercise

• Prof. Dr. Cora Weigert, Prof. Dr. Andreas Peter 

Metabolic Neuroimaging

• Prof. Dr. Hubert Preißl, Dr. Stephanie Kullmann 

Pancreatic Beta Cell Function

• PD Dr. Felicia Gerst 

Molecular Cell Biology

• Dr. Gencer Sancar (Junior Research Group)